Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Monitoring late-onset toxicities in phase I trials using predicted risks.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Monitoring late-onset toxicities in phase I trials using predicted risks.
Monitoring late-onset toxicities in phase I trials using predicted risks. Biostatistics. 2008 Jul; 9(3):442-57.
View in:
PubMed
subject areas
Bayes Theorem
Brain Neoplasms
Clinical Trials, Phase I as Topic
Dose-Response Relationship, Drug
Drug Design
Drug Evaluation
Drug Monitoring
Drug-Related Side Effects and Adverse Reactions
Humans
Markov Chains
Maximum Tolerated Dose
Monte Carlo Method
Radiation-Sensitizing Agents
Research Design
Risk
Time
Treatment Outcome
authors with profiles
Yuan Ji